Background

Adenoviruses typically produce a mild, self-limiting infection in young infants. These infections affect the upper and lower respiratory tracts, gastrointestinal tracts, and conjunctiva. In patients with compromised immunity, the disease is more severe and spreads more easily. Fatality rates for untreated severe adenovirus pneumonia or disseminated disease may exceed 50%. 

Individuals with DS may experience a higher frequency of infections, including viral infections, usually of the upper respiratory tract. Increased severity and a prolonged course of disease characterize infections in this population, partially but not exclusively attributed to defects of the immune system. Thus, this study aimed to evaluate the clinical characteristics and disease severity in children with DS and adenovirus infection

Introduction

Adenoviruses are non-enveloped, double-stranded DNA viruses that cause a variety of clinical symptoms in people.¹ Adenoviruses are members of the Adenoviridae family, specifically the genus Mastadenovirus. There are seven species (A through G) and fifty-two serotypes identified.

The structure of an adenovirus is icosahedral with a capsid. A viral capsid's capsomere component is made up of many proteins. A viral capsid is the protein shell that envelops and shields its nucleic acid, while a capsomere is a subunit of a viral capsid made up of several proteins.²

There are 252 capsomeres in the icosahedral capsid with 240 hexons from the faces, and 12 pentons are located at the vertices. Every penton has a thin fibre. Two key core proteins are linked to the double-stranded linear DNA, which also has a 55-kDa protein covalently bonded to its 5′ ends. The size of adenovirus is about 90-100nm³ Adenovirus are double-stranded, linear DNA viruses known as HAdVs have genome sizes that range from 34 to over 37 kb and include about 40 genes. ⁴ Adenoviruses with more than 100 antigenic varieties have been found to infect birds (aviadenoviruses) and mammals (mastadenoviruses); 47 human adenovirus variants have been characterized, and five more potential types are now being researched.³ 

Adenoviruses primarily induce self-limited respiratory and gastrointestinal symptoms when there is little seasonal change. (GI) or chronic conjunctivitis all year long. Aerosolized droplet inhalation, direct conjunctival inoculation, orofecal spread, and contact with contaminated tissue or blood are the possible modes of transmission.¹ Infections with HAdV are easily spread and might even be extremely infectious in certain cases. Infections can create local outbreaks with severe courses, sometimes even leading to a fatal end in immunocompetent persons, even if the clinical courses are often mild and self-limiting. Nonetheless, adenoviruses are especially significant in individuals with significantly compromised immune responses, for whom viral illness is linked to elevated rates of morbidity and death. As such, infections in this context are a major topic of this research.⁴

Latent, productive, or abortive infections are all possible. Viral genome transcription occurs in the nucleus, mRNA translation occurs in the cytoplasm, and virions self-assemble in the nucleus during productive infections. Viral DNA is incorporated into the host genome in transformed, malignant, and latent infections. Productive infections also contain virus-host DNA recombinants.³

Brief overview of Down Syndrome (DS) 

Down syndrome (DS) is the most frequent genetic condition associated with intellectual disability, and it is caused by a trisomy of Homo sapiens chromosome 21 and is named after John Langdon Down the first physician to describe it meticulously.⁵,⁶ Chromosomes contain genes that guide the organism to develop and execute certain functions. Most human cells contain 23 pairs of chromosomes, one from each parent, totalling 46 chromosomes.⁶

It falls within the group of chromosomal disorders known as aneuploidy, which is defined as an abnormal chromosome number produced by an extra or missing chromosome. The majority of aneuploid patients have trisomy (three copies of a chromosome) rather than monosomy (one copy).⁷ People with Down syndrome have a complete or partial extra copy of chromosome 21, giving them a total of 47 chromosomes. The syndrome is also known as 47, XX,+21 in females and 47 ,XY,+21 in males, denoting the additional chromosome 21.⁶

Key characteristics and health implications of DS.

Children with Down syndrome typically delay reaching major developmental milestones compared to their peers. People with the syndrome are also more likely to be born with heart defects, as well as a higher chance of having hearing and vision issues.⁶ Such individuals may also exhibit a particular set of symptoms and manifestations that impact many body systems, but there is significant variance across individuals. Individuals with Down syndrome are typically small in stature, with short fingers, hypotonia, and atlantoaxial instability. Epicanthic folds, a flat nasal bridge and occiput, a small mouth and ears, and up-slanting palpebral fissures are all features of the face. Congenital heart problems are frequent, notably the atrioventricular septal defect (AVSD).⁵ Individuals with Down syndrome are also more likely to develop certain health conditions than the general population, such as hypothyroidism, obstructive sleep apnea, epilepsy, hearing and vision problems, haematological disorders (including leukaemia), recurrent infections, anxiety disorders, and early-onset Alzheimer disease.⁵ 

Epidemiology of Down Syndrome

According to the CDC, approximately one out of every 1,000 children and teenagers (ages 0 to 19) in the United States has Down syndrome. This means that in 2002, approximately 83,000 children and teenagers had Down syndrome.⁸ In 2008, researchers estimated that approximately one out of every 1,200 people (children, adolescents, and adults) in the United States had Down syndrome. In 2008, approximately 250,700 children, teenagers, and adults in the United States had Down syndrome.⁹

Diagnosis of Down Syndrome

Down syndrome is diagnosed using chromosome analysis, either prenatally or postnatally. Pregnant women in the United States have blood tests for chromosomal abnormalities and spina bifida, followed by a prenatal cytogenic diagnosis. Chorionic-villus sampling, amniocentesis, and fetal ultrasound are all diagnostic tests. Isolating fetal cells from maternal blood could potentially replace amniocentesis as a prenatal diagnostic method.¹⁰

This review of the scientific literature aims to offer an in-depth evaluation and summarize the current studies on the relationship between adenovirus and people with Down's syndrome (DS). The specific objectives study aims to advance knowledge of the intricate relationship between Down Syndrome and Adenovirus, with implications for clinical practice, public health initiatives, and treatment of patients in this susceptible population.

Challenges faced by individuals with DS in the context of infections.

It is widely accepted that DS children are more prone to infections than normal children, with most studies agreeing that these primarily affect the respiratory tract. Although some DS children may not present with frequent infections, the course of their infection illnesses may be prolonged and have increased severity when compared with non-DS children.¹¹ 

A review of a large cohort of Down syndrome children in Sweden and Denmark found a 12-fold increased risk of infection-related mortality, particularly septicaemia.¹² This excess mortality was consistent with data from a recent study, which found that DS children had a 30% higher risk of death from sepsis than other children hospitalized for sepsis, even after controlling for confounding factors such as pathogens and co-morbid conditions.¹³ there are significant effects on the immune system of children with Down Syndrome. Some of the immune defects in children with DS include reduced T and B cell counts, absence of normal lymphocyte expansion in infancy, smaller thymus size than age-matched controls, reduced naive T cell percentages, suboptimal antibody responses to immunizations, decreased total and specific immunoglobulin A in saliva, and decreased immunoglobulin A in saliva.¹¹

Individuals with DS may have lower antibody responses to immunizations, making them more susceptible to illness.¹⁴ They also have an increased chance of acquiring autoimmune illnesses, such as hypothyroidism and celiac disease, which can complicate their infection profile.¹¹

Pathogenesis of Adenovirus

Adenovirus infections typically affect epithelial cells in the lungs and gastrointestinal system. Adenoviruses penetrate host cells and impede mRNA production and transfer to the cytoplasm. This disruption of biological mechanisms causes cell lysis and death. The viral penton protein has been found to have a toxic impact, inducing cells to detach from monolayers in laboratory conditions. However, the clinical implications are unknown. Adenoviruses can cause latent infections in lymphoid tissues such as adenoids, tonsils, and Peyer's patches, long after acute symptoms have been resolved. Adenoviruses create a short, structured RNA molecule (VA RNA), which limits the host cell's capacity to make interferon, allowing the virus.¹⁵ 

Adenoviruses also can cause latent infections in lymphoid tissues such as adenoids, tonsils, and Peyer's patches, long after acute symptoms have been resolved. They create VA RNA, a tiny, structured RNA molecule that prevents the host cell from producing interferon. This allows the virus to thrive and avoid immune responses. After viral replication, adenoviral DNA may remain in host cells as circular extra-chromosomal DNA or be incorporated into the host genome. This persistence may lead to the development of long-term complications such as Swyer-James syndrome and chronic respiratory diseases.

Adenoviruses' delayed cytopathology and cell death prolong host cell function, promoting viral reproduction and survival.¹⁶

Modes of transmission

Adenoviruses are primarily transmitted through person-to-person contact, respiratory droplets, and contaminated surfaces. Infection can occur through respiratory secretions or contaminated objects. Airborne or waterborne transmission can occur through swimming in lakes with inadequate chlorine levels. The virus is easily spread in crowded environments like daycares, dormitories, hospitals, and nursing homes.¹⁷

Common manifestations of Adenovirus infection with Down Syndrome

Children with Down syndrome are more likely to contract viral infections and suffer from them more severely. Of the 486 children hospitalized with adenoviral infection, 11 (2.28%) were diagnosed with Down syndrome. Children with Down syndrome had higher rates of complications (18.2% vs. 2.4%, P = 0.008), intensive care unit admissions (36.4% vs. 2.4%, P < 0.001), and longer hospital stays (17 ± 15.9 days vs. 4.46 ± 3.16, P = 0.025). Infants with Down syndrome who endured hospitalization with adenovirus infection indicate a high-risk group and should be closely monitored.¹⁸

Epidemiological studies examining the prevalence and severity of Adenovirus infections in individuals with DS.

Epidemiological studies have found that people with Down syndrome (DS) are more vulnerable to adenovirus infections, with a higher frequency and severity of viral infections than the general population. 

Children with Down syndrome are especially vulnerable to adenovirus infections, with a higher rate of complications, hospitalizations, and a higher risk of severe outcomes when compared to children without the condition. Adeno Virus is responsible for at least 5 to 10% of pediatric and 1 to 7% of adult respiratory tract infections (RTIs).¹⁹ 

These findings highlight the importance of monitoring and addressing adenovirus infections in individuals with DS to avoid severe complications and improve clinical

Comparison of Adenovirus infection symptoms and complications in individuals with and without Down Syndrome.

Adenovirus infections occur in both Down Syndrome and non-Down Syndrome categories, but they differ in terms of susceptibility, severity, complications, and treatment.

Adenovirus infections in people with Down Syndrome are more likely to result in complications like chronic lung disease, severe infections, intestinal blockage (intussusception), and hepatitis.

Individuals with Down Syndrome who have adenovirus infections are more likely to be admitted to the intensive care unit and stay longer in the hospital than those who do not.²⁰

Current approaches to managing Adenovirus infections in individuals with DS.

There is no single standard management for Down syndrome. Management is based on each individual physical and intellectual needs as well as his or her personal strengths and limitations. It has been suggested that management strategies of diet and exercise should be encouraged in this population.²¹ Also, the preventive approach, light exercises such as aerobic exercises at moderate intensity, light resistance training, dance activities, cycling and swimming are excellent for the efficiency of the cardiovascular system. However, the exercise load should at all times be kept at a low threshold

Challenges and considerations in developing effective prevention and treatment strategies specific to this population.

Adenovirus infections are frequently diagnosed using particular testing methods, such as shell vial cell culture, rapid antigen tests, and molecular biology tests such as PCR. Having access to and competence in performing these specialized tests in individuals with Down syndrome can be a challenge, affecting the timely and accurate diagnosis of adenovirus infections in this population.²² Also, there is insufficient information on the severity and clinical course of adenovirus infections in children with Down syndrome. This inadequate understanding might complicate the identification of adenovirus infections in persons with Down Syndrome, as the specific features and symptoms of the infection in this population may not be well-documented.²³ Again, adenovirus infections in Down syndrome individuals may cause uncommon symptoms or problems, making it difficult to recognize and separate from other illnesses. This might cause delays in diagnosis and treatment. Furthermore, children with Down syndrome are more prone to have problems, such as increased admission rates and longer hospital stays. This increased risk may make it difficult to accurately diagnose and manage viral infections.²³

Future directions and research needs for improving Adenovirus management in individuals with DS are strategies that needs to be put in place to improve adenovirus management in people with Down Syndrome. This includes personalized vaccines, quick diagnostic techniques, evidence-based therapeutic guidelines, antiviral medicines, longitudinal studies on DS health outcomes, and collaborative efforts among academics, clinicians, and advocacy groups are critical for improving adenovirus management. Also, there should be long-term research to examine the impact of DS on health outcomes, as well as implementing public health strategies to avoid outbreaks and reduce transmission risk. 

Summary

They normally cause a minor, self-limiting condition. However, this infection can cause significant morbidity and mortality in certain individuals, particularly immunocompromised youngsters. Children with Down syndrome are more likely to experience frequent and severe viral infections. There is limited understanding of the severity and clinical course of adenovirus infections in children with Down syndrome.